Wolfe Research Upgrades Madrigal Pharmaceuticals (MDGL) to Outperform

August 4, 2026 5:07 AM EDT Send to a Friend
(Updated - August 4, 2026 5:08 AM EDT)

Wolfe Research analyst Andy Chen upgraded Madrigal Pharmaceuticals (NASDAQ: MDGL) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login